Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 390

FOLFOX-A in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction Adenocarcinoma

FOLFOX-A in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction Adenocarcinoma
Conditions:   Gastro-Esophageal Junction Adenocarcinoma;   Gastric Cancer
Interventions:   Drug: Nab-paclitaxel 150 mg/m^2;   Drug: Oxaliplatin 85 mg/m^2;   Drug: 5-FU 1200 mg/m^2 x 2 D;   Drug: Leucovorin 400 mg/m^2
Sponsors:   Al B. Benson, III, MD;   Celgene Corporation;   Big Ten Cancer Research Consortium
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

August 15, 2019 / by / in
Comments